M&A: Page 21


  • AngioDynamics posts bigger net loss, looks to oncology

    Executives said the company's two recent acquisitions signal a shift in investment to the oncology section of the business.

    By Tyler Woods • Oct. 1, 2018
  • Venus to buy Keystone, moving into Boston Sci's TAVR turf

    The move furthers Venus' aspirations to grow into a global transcatheter heart valve company and, by extension, advance China's bid to supercede the U.S. as the dominant medtech force.

    By Sept. 26, 2018
  • EY warns stagnant R&D, data use threatens medtech growth

    Medtech R&D investment of $15.9 billion remained "relatively unchanged" in 2017 — roughly $1 billion less than the $16.4 billion companies gave back to investors through share buybacks and dividends.

    By David Lim • Sept. 24, 2018
  • GeekWire: Google's Nest has healthcare ambitions

    Nest secretly acquired Senosis Health, maker of smartphone-based monitoring systems for conditions like osteoporosis and newborn jaundice, according to internal communications and financial documents.

    By Meg Bryant • Sept. 21, 2018
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Medtronic strikes $1.6B takeover of Mazor Robotics

    The acquisition moves the device giant into the robotic-assisted surgery sector.

    By Sept. 21, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Athenahealth extends acquisition bid deadline

    The delay is to allow for a new strategic buyer to prepare its bid, a source close to the matter said.

    By Meg Bryant • Sept. 19, 2018
  • Trimedx to buy Aramark unit in $300M health tech merger

    Two major providers of healthcare technology management services come together in the pact.

    By Sept. 19, 2018
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    AngioDynamics to buy RadiaDyne for radiotherapy devices

    RadiaDyne thinks AngioDynamics' commercial infrastructure will help it to grow sales beyond the $6 million achieved over the past 12 months.  

    By Sept. 14, 2018
  • J&J buys EIT for 3D-printed titanium spinal implants

    The devices are designed to increase the number of surgeries that are successful the first time.

    By Sept. 13, 2018
  • Image attribution tooltip
    UpperEdge
    Image attribution tooltip

    UK-based Medopad snaps up health IT startup Sherbit

    Founded in 2016, Sherbit works with health systems on chronic disease management using real-time data and analytics.

    By Meg Bryant • Sept. 12, 2018
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Alcon to shift HQ to Switzerland after Novartis spinoff

    The eye care unit already has operations in Geneva, and plans to list on Swiss stock exchanges upon becoming a standalone company. 

    By Ned Pagliarulo • Sept. 11, 2018
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Stryker buys surgical lighting company for $190M

    Photonics and intracavity lighting company Invuity is the latest acquisition in Stryker's ongoing purchasing spree.

    By Rebecca Pifer • Sept. 11, 2018
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Becton Dickinson sells bioprocessing business to Thermo Fisher

    Divesting the unit will allow Becton to better focus its life sciences division on disease and therapy research and clinical diagnostics.

    By Sept. 10, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Biotech billionaire Phillip Frost charged by SEC, sending Opko shares sliding

    The SEC announced the charges Friday, alleging the Opko CEO and nine others manipulated stock prices in "classic pump-and-dump schemes."

    By Andrew Dunn • Updated Sept. 8, 2018
  • Image attribution tooltip
    Wikimedia
    Image attribution tooltip

    BTG acquires Irish device maker Novate Medical

    The $20 million cash deal could reach $150 million if certain business milestones are met.

    By David Lim • Sept. 7, 2018
  • Boston Scientific inks $600M Augmenix buyout

    The focus of the deal is a device to reduce the side effects of prostate cancer radiotherapy.

    By Sept. 7, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Amazon's stock valuation hits $1T

    The e-tailer and tech company is still far behind its primary rivals in terms of profitability, but its explosive growth has wowed investors, who show no signs of losing faith in Amazon's future.

    By Ben Unglesbee • Sept. 5, 2018
  • Stryker buys spine device maker K2M for $1.4B

    The acquisition is expected to give Stryker some needed heft in the category, adding several differentiated products in faster-growth areas of the specialty.

    By Aug. 31, 2018
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Wright Medical inks $435M takeover of implant firm Cartiva

    An arthritis implant with fast-growing sales is the focal point of the acquisition.

    By Aug. 28, 2018
  • Robotic surgery market is about to get crowded, report says

    GlobalData predicts larger companies will accelerate investment in surgical robotics through acquisitions and partnerships.

    By Aug. 24, 2018
  • Pfizer inks marketing deal for Exact's Cologuard

    Exact said about 401,000 tests were performed during the first six months of 2018, leading to revenue of $193 million. The CEO now expects $700 million in sales for next year.

    By Andrew Dunn • Aug. 22, 2018
  • Image attribution tooltip
    UpperEdge
    Image attribution tooltip

    Healthcare execs see Amazon as biggest disrupter

    Apple and Google were among those also feared, though Amazon held a giant lead in the survey, according to a report from Reaction Data.

    By Meg Bryant • Aug. 22, 2018
  • AngioDynamics buys biopsy sealant technology from Surgical Specialties

    The acquisition will expand the company’s portfolio of oncology devices.

    By Aug. 16, 2018
  • Boston Scientific inks Veniti takeover to access untapped stent market

    The $160 million buy moves the company into the nascent venous stent sector.

    By Aug. 9, 2018
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Varian acquires maker of patient monitoring system

    The radiation therapy company said the buy expands its motion-management portfolio, part of its cancer care strategy.

    By Aug. 7, 2018